Long-Term Outcomes in SLE at Peking University People's Hospital
A Prospective Cohort Study on Long-Term Outcomes in Patients With Systemic Lupus Erythematosus at Peking University People's Hospital
Peking University People's Hospital
1,000 participants
May 21, 2020
OBSERVATIONAL
Conditions
Summary
This study aims to prospectively follow patients diagnosed with Systemic Lupus Erythematosus (SLE) at Peking University People's Hospital, assessing long-term outcomes such as disease activity, organ involvement, survival, and quality of life. Findings will support individualized patient management and contribute to understanding disease progression in the Chinese population.
Eligibility
Inclusion Criteria2
- All patients must meet at least one of the following classification criteria for Systemic Lupus Erythematosus (SLE):
- The 1997 American College of Rheumatology (ACR) Revised Classification Criteria; The 2012 Systemic Lupus International Collaborating Clinics (SLICC) Classification Criteria; The 2019 EULAR/ACR Classification Criteria for SLE. All patients must be over the age of 18 and competent to provide written consent.
Exclusion Criteria1
- Patients less than 18 years of age and patients who are unable to consent are excluded from the study.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07005479